Cabozantinib

Cabozantinib (INN) (development code name XL184; marketed under the trade name Cabometyx) is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and has been shown to reduce tumor growth, metastasis, and angiogenesis. It was discovered and developed by Exelixis Inc.

单词	Cabozantinib
释义	Cabozantinib 英语百科 Cabozantinib Cabozantinib (INN) (development code name XL184; marketed under the trade name Cabometyx) is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and has been shown to reduce tumor growth, metastasis, and angiogenesis. It was discovered and developed by Exelixis Inc.
随便看	Ethyl vanillin Ethyl vinylacetate ethyl vinyl carbinol ethylvinylether ethyl vinyl ether ethyl vinyl ketone ethyl vinyl sulfide ethylvinyl sulfide ethyl violet ethyl violet azide ethyl violet azide b. ethyl violet azide broth ethyl xanthate ethylxanthate ethylxanthates ethylxanthic disulfide ethylxanthogenate ethyl xanthogenate ethylxanthogenates ethyl xanthogen disulfide ethyl xanthogenic acid ethylzation ethylzer ethyl α cyanoacrylate ethyl ρ hydroxybenzoate